What is the recommended treatment for ringworm (tinea infection)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Ringworm (Tinea Infection)

For ringworm (tinea) infections, oral therapy with griseofulvin or terbinafine is recommended as first-line treatment, with the specific agent chosen based on the causative organism. 1, 2

Diagnosis

  • Accurate diagnosis is essential before starting treatment - identification should be made either by direct microscopic examination of infected tissue in potassium hydroxide solution or by culture on appropriate medium 2
  • In high-risk populations or when clinical features are highly suggestive (scaling, lymphadenopathy, alopecia), treatment may be initiated before culture results are available 1

Treatment Approach

Topical Therapy

  • Topical therapy alone is not recommended for tinea capitis (scalp ringworm) 1
  • For tinea corporis (body), tinea cruris (groin), and tinea pedis (feet), topical antifungal agents are often effective as first-line treatment 3, 4
  • Common topical agents include:
    • Azoles (clotrimazole, miconazole)
    • Allylamines (terbinafine, naftifine)
    • Treatment duration: 2 weeks for tinea corporis/cruris, 4 weeks for tinea pedis 4

Oral Therapy

For Tinea Capitis:

  1. Griseofulvin:

    • First-line treatment for Microsporum species infections 1
    • Dosage:
      • Children: 10-20 mg/kg/day for 6-8 weeks
      • Adults: 500 mg daily (can start with 0.75-1.0 g/day for widespread lesions) 2
    • Only licensed product for tinea capitis in children in the UK 1
  2. Terbinafine:

    • First-line for Trichophyton species infections 1
    • Dosage based on weight:
      • <20 kg: 62.5 mg daily
      • 20-40 kg: 125 mg daily
      • 40 kg: 250 mg daily

    • Treatment duration: 2-4 weeks 1

For Extensive Tinea Corporis/Cruris:

  • Oral therapy is indicated when infection is widespread or adjacent to eyes, ears, or mouth 5
  • Options include:
    • Fluconazole: 50-100 mg daily or 150 mg once weekly for 2-3 weeks 6
    • Itraconazole: 100 mg daily for 2 weeks or 200 mg daily for 7 days 6
    • Terbinafine: 250 mg daily for 1-2 weeks 6

Treatment Selection Algorithm

  1. Identify the type of tinea infection:

    • Tinea capitis (scalp) - requires oral therapy
    • Tinea corporis/cruris/pedis - topical therapy for limited disease, oral for extensive disease
  2. For tinea capitis:

    • If Microsporum species or unknown: Griseofulvin for 6-8 weeks
    • If Trichophyton species: Terbinafine for 2-4 weeks
  3. For tinea corporis/cruris/pedis:

    • Limited disease: Topical azole or allylamine
    • Extensive disease: Oral therapy as outlined above

Adjunctive Measures

  • For tinea capitis, topical antifungal shampoos (ketoconazole 2%, selenium sulfide 1%) can help reduce transmission of spores 1
  • General hygiene measures should be observed to control sources of infection or reinfection 2
  • For tinea capitis due to T. tonsurans, screening of family members and close contacts is warranted 1

Treatment Failure Considerations

  • Ensure correct diagnosis was made initially
  • Consider lack of compliance, suboptimal absorption, or relative insensitivity of the organism 1
  • For clinical improvement but ongoing positive mycology, continue current therapy for 2-4 more weeks 1
  • If no clinical improvement, switch to second-line therapy:
    • If initial treatment was griseofulvin, switch to terbinafine for Trichophyton infections
    • If initial treatment was terbinafine, switch to griseofulvin for Microsporum infections
    • Itraconazole (5 mg/kg/day for 2-4 weeks) can be used as an alternative 1

Important Caveats

  • Treatment should continue until the infecting organism is completely eradicated as indicated by appropriate clinical or laboratory examination 2
  • Clinical relapse will occur if medication is not continued until the organism is eradicated 2
  • Oral antifungal drugs are not effective against bacterial infections, candidiasis, or other non-dermatophyte fungal infections 2
  • The use of systemic antifungals is not justified for minor or trivial dermatophyte infections that will respond to topical agents alone 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Topical antifungal treatments for tinea cruris and tinea corporis.

The Cochrane database of systematic reviews, 2014

Research

Topical treatment of common superficial tinea infections.

American family physician, 2002

Research

Oral therapy of common superficial fungal infections of the skin.

Journal of the American Academy of Dermatology, 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.